Chimera Bioengineering: Detailed Company Information & Corporate Profile
Contact top employees from
Chimera Bioengineering
Summary
The business currently specializes in Biotechnology area. Vlad Hogenhuis is the Chief Executive Officer at the company. The company has 10-50 employees. Register with SignalHire to connect with Chimera Bioengineering employees and management.
| Chimera Bioengineering Website | chimera.bio |
| Industries | |
| Chimera Bioengineering Headquarters address | 329 Oyster Point Blvd, South San Francisco, California, 94080 US |
| Company Size | 10-50 employees |
| Specialties | CAR T cell therapeutics, drug responsive control systems, RNA engineering / biology, cellular immunotherapy, ribozymes |
| Founded | 2015 |
| Estimated Annual Revenue | $1 - 10M |
| Updated: | 2026-07-01 |
Workforce Turnover
Length of Employment
Chimera Bioengineering's workforce includes employees across a wide range of tenure levels.
25% have been with the company for 3 to 4 years25% have been with the company for 5 to 7 years38% have been with the company for 8 to 10 years13% have been with the company for more than 11 yearsContact top employees from
Chimera Bioengineering
Vlad HogenhuisChief Executive Officer
Companies Similar to Chimera Bioengineering
Chimera Bioengineering Corporate Information: FAQ
Chimera Bioengineering operates in the Biotech industries. More details can be found on the official website: chimera.bio.
Chimera Bioengineering has offices located in South San Francisco, US.
The headquarters of Chimera Bioengineering are located in South San Francisco, United States.
Chimera Bioengineering currently employs 10-50 people.
Data Privacy
GDPR COMPLIANT
SignalHire complies with the General Data Protection Regulation (GDPR). SignalHire follows GDPR requirements, including but not limited to rights of data subjects to access, correct, or delete their personal information and supports the right to be forgotten.
CCPA COMPLIANT
SignalHire is CCPA-compliant and provides California residents the right to know, access, opt out, and request deletion of their personal data.
